Introduction: Simultaneous pancreas-kidney transplantation (SPKT) outcomes are conditioned in the short-term mostly by post-operative complications. In the long-term, cardiovascular (CV) disease and immunological loss are the main limitations to transplant survival. Aims: To analyse retrospectively the results from 150 SPKT performed at our centre. Patients and Methods: The 81 females and 69 males had a mean age of 35±6 years; they were diabetic for 24±6 years and had been on dialysis for 30±21months (except 5 preemptive). Anti-lymphocyte globulin, tacrolimus, mycophenolate and steroids were used as immunosuppressive therapy. Deceased-donor mean age was 28±11 years. In 28.7% the transplant was performed with 6 HLA-mismatches. Re...
OBJECTIVE — To determine whether short-term improvement in pancreas graft survival with simultaneous...
Background: Simultaneous pancreas-kidney transplantation (SPK) is an established therapy for diabete...
OBJECTIVE In patients with type 1 diabetes and end-stage renal disease, it is controversial whether ...
Transplant Proc. 2003 May;35(3):1107-8. Combined pancreas-kidney transplantation: a new program i...
(1) Background: Simultaneous pancreas-kidney transplantation (SPKT) is a standard therapeutic option...
Background. Simultaneous pancreas-kidney transplantation (SPKT) is one of the treatments for insulin...
Objectives: Simultaneous pancreatic-renal transplant is an effective treatment for insulin-dependent...
In patients with end-stage chronic kidney disease (CKD) and type 1 diabetes mellitus (DM 1), simult...
Background and objectives: Simultaneous pancreas-kidney transplantation (SPK) is regarded as the tre...
Introduction: Simultaneous pancreas-kidney transplantation (SPKT) is an effective treatment for pati...
OBJECTIVE — To quantify the incremental survival benefit of the pancreas allograft in si-multaneous ...
Background. Simultaneous pancreas-kidney (SPK) transplantation is.-in accepted therapy for type 1 di...
In diabetic patients cardiovascular morbidity and mortality is still a major problem. Our aim was to...
Simultaneous pancreas-kidney transplantation (SPK) carries about a 7%-22% risk of technical failure,...
Patient survival after pancreas after kidney transplant (PAK) has been reported to be inferior to pa...
OBJECTIVE — To determine whether short-term improvement in pancreas graft survival with simultaneous...
Background: Simultaneous pancreas-kidney transplantation (SPK) is an established therapy for diabete...
OBJECTIVE In patients with type 1 diabetes and end-stage renal disease, it is controversial whether ...
Transplant Proc. 2003 May;35(3):1107-8. Combined pancreas-kidney transplantation: a new program i...
(1) Background: Simultaneous pancreas-kidney transplantation (SPKT) is a standard therapeutic option...
Background. Simultaneous pancreas-kidney transplantation (SPKT) is one of the treatments for insulin...
Objectives: Simultaneous pancreatic-renal transplant is an effective treatment for insulin-dependent...
In patients with end-stage chronic kidney disease (CKD) and type 1 diabetes mellitus (DM 1), simult...
Background and objectives: Simultaneous pancreas-kidney transplantation (SPK) is regarded as the tre...
Introduction: Simultaneous pancreas-kidney transplantation (SPKT) is an effective treatment for pati...
OBJECTIVE — To quantify the incremental survival benefit of the pancreas allograft in si-multaneous ...
Background. Simultaneous pancreas-kidney (SPK) transplantation is.-in accepted therapy for type 1 di...
In diabetic patients cardiovascular morbidity and mortality is still a major problem. Our aim was to...
Simultaneous pancreas-kidney transplantation (SPK) carries about a 7%-22% risk of technical failure,...
Patient survival after pancreas after kidney transplant (PAK) has been reported to be inferior to pa...
OBJECTIVE — To determine whether short-term improvement in pancreas graft survival with simultaneous...
Background: Simultaneous pancreas-kidney transplantation (SPK) is an established therapy for diabete...
OBJECTIVE In patients with type 1 diabetes and end-stage renal disease, it is controversial whether ...